Agios Pharmaceuticals, Inc.

AGIO

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001439222

SEC filings (opens in a new tab)

In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Agios Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of AGIO: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	206	1	208	+3
Shares	58.1M	4.86M	58.1M	+4.82M (+9.1%)
Value	$2.51B	$209.5M	$2.58B	+$284.9M (+12.4%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to AGIO in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	5,021,767	$223.1M	0.00%
Polar Capital Holdings Plc	1,002,036	$44.5M	0.26%
Vestal Point Capital, LP	760,000	$33.8M	2.66%
Cutter Capital Management, LP	186,623	$8.29M	2.45%
Summit Partners Public Asset Management, LLC	101,730	$4.52M	0.20%
Silvercrest Asset Management Group LLC	79,885	$3.55M	0.02%
Exome Asset Management LLC	66,200	$2.94M	1.99%
Caption Management, LLC	46,162	$2.05M	0.22%
Cantor Fitzgerald, L. P.	43,708	$1.94M	0.18%
Franklin Resources Inc	36,317	$1.50M	0.00%
HRT Financial LP	28,754	$1.28M	0.01%
ADAR1 Capital Management, LLC	21,300	$946.4K	0.16%
Prelude Capital Management, LLC	21,000	$933.0K	0.07%
Intech Investment Management LLC	20,078	$892.1K	0.01%
SG Americas Securities, LLC	15,864	$705.0K	0.00%
Verition Fund Management LLC	7,097	$315.3K	0.00%
Quantbot Technologies LP	3,284	$145.9K	0.01%
Sterling Capital Management LLC	194	$8.62K	0.00%
True Wealth Design, LLC	166	$7.38K	0.00%
Capital Performance Advisors LLP	155	$6.89K	0.00%
Bessemer Group Inc	120	$5.00K	0.00%
CarsonAllaria Wealth Management, Ltd.	110	$4.89K	0.00%
Johnson Financial Group, Inc.	76	$3.38K	0.00%
Riverview Trust Co	11	$489	0.00%
DiNuzzo Private Wealth, Inc.	2	$89	0.00%
National Bank of Canada	1	$44	0.00%
Hemington Wealth Management	16	$0	0.00%

Sold out (24)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of AGIO in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Laurion Capital Management LP	248,395	$10.7M
Woodline Partners LP	113,378	$4.89M
Acuta Capital Partners, LLC	78,700	$3.39M
Edgestream Partners, L.P.	42,076	$1.81M
Balyasny Asset Management LLC	41,793	$1.80M
Seven Eight Capital, LP	39,262	$1.69M
Y-Intercept (Hong Kong) Ltd	25,945	$1.12M
Scientech Research LLC	17,592	$758.6K
Pennant Investors, LP	15,100	$651.1K
Group One Trading, L.P.	10,103	$435.6K
Aquatic Capital Management LLC	8,800	$379.5K
Principal Financial Group Inc	7,594	$327.5K
Fox Run Management, L.L.C.	6,818	$294.0K
Squarepoint Ops LLC	6,622	$285.5K
Bridgefront Capital, LLC	4,965	$214.1K
Virtu Financial LLC	4,960	$214.0K
Acadian Asset Management LLC	864	$37.0K
Pacer Advisors, Inc.	437	$18.8K
Sunbelt Securities, Inc.	225	$9.70K
Valley National Advisers Inc	157	$6.00K
Stephens Consulting, LLC	55	$2.37K
Twin Tree Management, LP	52	$2.24K
Mather Group, LLC.	55	$1.61K
Innealta Capital, LLC	17	$733

Not filed for Q3 2024 yet (1)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AGIO in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	4,859,002	$209.5M